Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT04975399 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped Business objectives have changed

Conditions

Interventions

Sponsor

Celgene